Nebraska Cancer Specialist

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 11 trial
• Phase 21 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Eisai Inc.1 trial
• Pellficure Pharmaceuticals, Inc1 trial

Closed trials

• Completed

  A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer

  NCT06188559· Phase 2· Eisai Inc.· Source

• Terminated

  Study of PCUR-101 in Combination With ADT in Patients With mCRPC

  NCT04677855· Phase 1· Pellficure Pharmaceuticals, Inc· Source